Accueil du site > Equipes > Fonctionnalité et dynamique du tissu cutané (D. Sigaudo-Roussel) > Publications
Publications
60. [An ionic channel involved in the skin protection against pressure].
Fromy B, Lingueglia E, Sigaudo-Roussel D, Saumet JL, Lazdunski M
(2013) Med Sci (Paris) 29 : 130-2
59. In vivo skin biophysical behaviour and surface topography as a function of ageing.
Pailler-Mattei C, Debret R, Vargiolu R, Sommer P, Zahouani H
(2013) J Mech Behav Biomed Mater :
2012 [Top] 10
58. Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein.
Valdameri G, Genoux-Bastide E, Peres B, Gauthier C, Guitton J, Terreux R, Winnischofer SM, Rocha ME, Boumendjel A, Di Pietro A
(2012) J Med Chem 55 : 966-70
57. 6-halogenochromones bearing tryptamine: one-step access to potent and highly selective inhibitors of breast cancer resistance protein.
Valdameri G, Genoux-Bastide E, Gauthier C, Peres B, Terreux R, Winnischofer SM, Rocha ME, Di Pietro A, Boumendjel A
(2012) ChemMedChem 7 : 1177-80
56. Deferasirox-induced renal impairment in children: an increasing concern for pediatricians.
Dubourg L, Laurain C, Ranchin B, Pondarre C, Hadj-Aissa A, Sigaudo-Roussel D, Cochat P
(2012) Pediatr Nephrol 27 : 2115-22
55. Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.
Valdameri G, Gauthier C, Terreux R, Kachadourian R, Day BJ, Winnischofer SM, Rocha ME, Frachet V, Ronot X, Di Pietro A, Boumendjel A
(2012) J Med Chem 55 : 3193-200
54. Asic3 is a neuronal mechanosensor for pressure-induced vasodilation that protects against pressure ulcers.
Fromy B, Lingueglia E, Sigaudo-Roussel D, Saumet JL, Lazdunski M
(2012) Nat Med :
53. Chronic sciatic nerve injury impairs the local cutaneous neurovascular interaction in rats.
Pelletier J, Fromy B, Morel G, Roquelaure Y, Saumet JL, Sigaudo-Roussel D
(2012) Pain 153 : 149-57
52. Heparan sulfate affects elastin deposition in fibroblasts cultured from donors of different ages.
Annovi G, Boraldi F, Moscarelli P, Guerra D, Tiozzo R, Parma B, Sommer P, Quaglino D
(2012) Rejuvenation Res 15 : 22-31
51. A synthetic chalcone as a potent inducer of glutathione biosynthesis.
Kachadourian R, Day BJ, Pugazhenti S, Franklin CC, Genoux-Bastide E, Mahaffey G, Gauthier C, Di Pietro A, Boumendjel A
(2012) J Med Chem 55 : 1382-8
50. Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein.
Valdameri G, Pereira Rangel L, Spatafora C, Guitton J, Gauthier C, Arnaud O, Ferreira-Pereira A, Falson P, Winnischofer SM, Rocha ME, Tringali C, Di Pietro A
(2012) ACS Chem Biol 7 : 322-30
49. Cigarette smoking and drinking behavior of migrant adolescents and young adults in Hanoi, Vietnam.
Nguyen LT, Rahman Z, Emerson MR, Nguyen MH, Zabin LS
(2012) J Adolesc Health 50 : S61-7
2011 [Top] 4
48. Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation.
Boumendjel A, Macalou S, Valdameri G, Pozza A, Gauthier C, Arnaud O, Nicolle E, Magnard S, Falson P, Terreux R, Carrupt PA, Payen L, Di Pietro A
(2011) Curr Med Chem 18 : 3387-401
47. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth.
Pez F, Dayan F, Durivault J, Kaniewski B, Aimond G, Le Provost GS, Deux B, Clezardin P, Sommer P, Pouyssegur J, Reynaud C
(2011) Cancer Res 71 : 1647-57
46. [The theory of punctuated equilibrium, a breakthrough in understanding cancer].
Reynaud C, Billaud M
(2011) Med Sci (Paris) 27 : 921-3
45. What can current stimulation tell us about the vascular function of endogenous prostacyclin in healthy rat skin in vivo?
Gohin S, Sigaudo-Roussel D, Conjard-Duplany A, Dubourg L, Saumet JL, Fromy B
(2011) J Invest Dermatol 131 : 237-44
2010 [Top] 3
44. Epigenetic silencing of lysyl oxidase-like-1 through DNA hypermethylation in an autosomal recessive cutis laxa case.
Debret R, Cenizo V, Aimond G, Andre V, Devillers M, Rouvet I, Megarbane A, Damour O, Sommer P
(2010) J Invest Dermatol 130 : 2594-601
43. Comparison of ex vivo and in vitro human fibroblast ageing models
Boraldi F, Annovi G, Tiozzo R, Sommer P, Quaglino D
(2010) MECHANISMS OF AGEING AND DEVELOPMENT 131 : 625-635
42. Lysyl oxidase silencing impairs keratinocyte differentiation in a reconstructed-epidermis model.
Le Provost GS, Debret R, Cenizo V, Aimond G, Pez F, Kaniewski B, Andre V, Sommer P
(2010) Exp Dermatol 19 : 1080-7
2009 [Top] 3
41. Characterization of the mechanical properties of a dermal equivalent compared with human skin in vivo by indentation and static friction tests.
Zahouani H, Pailler-Mattei C, Sohm B, Vargiolu R, Cenizo V, Debret R
(2009) Skin Res Technol 15 : 68-76
40. Lysyl oxidase like-1 dysregulation and its contribution to direct inguinal hernia.
Pascual G, Rodriguez M, Mecham RP, Sommer P, Bujan J, Bellon JM
(2009) Eur J Clin Invest 39 : 328-37
39. Self-etching increases matrix metalloproteinase expression in the dentin-pulp complex.
Lehmann N, Debret R, Romeas A, Magloire H, Degrange M, Bleicher F, Sommer P, Seux D
(2009) J Dent Res 88 : 77-82
2008 [Top] 6
38. Morpholino knockdown of lysyl oxidase impairs zebrafish development, and reflects some aspects of copper metabolism disorders.
Reynaud C, Baas D, Gleyzal C, Le Guellec D, Sommer P
(2008) Matrix Biol 27 : 547-60
37. Down-regulation of lysyl oxydase-like in aging and venous insufficiency.
Pascual G, Mendieta C, Mecham RP, Sommer P, Bellon JM, Bujan J
(2008) Histol Histopathol 23 : 179-86
36. Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation.
Debret R, Brassart-Pasco S, Lorin J, Martoriati A, Deshorgue A, Maquart FX, Hornebeck W, Rahman I, Antonicelli F
(2008) Biochim Biophys Acta 1783 : 1718-27
35. A p.C217R mutation in fibulin-5 from cutis laxa patients is associated with incomplete extracellular matrix formation in a skin equivalent model.
Claus S, Fischer J, Megarbane H, Megarbane A, Jobard F, Debret R, Peyrol S, Saker S, Devillers M, Sommer P, Damour O
(2008) J Invest Dermatol 128 : 1442-50
34. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlotzer-Schrehardt U, Pasutto F, Sommer P, Hornstra I, Kruse FE, Naumann GO, Reis A, Zenkel M
(2008) Am J Pathol 173 : 1724-35
33. Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta.
Behmoaras J, Slove S, Seve S, Vranckx R, Sommer P, Jacob MP
(2008) Rejuvenation Res 11 : 883-9
2007 [Top] 4
32. In vitro comparison of human fibroblasts from intact and ruptured ACL for use in tissue engineering.
Brune T, Borel A, Gilbert TW, Franceschi JP, Badylak SF, Sommer P
(2007) Eur Cell Mater 14 : 78-90
31. Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach.
Boraldi F, Annovi G, Carraro F, Naldini A, Tiozzo R, Sommer P, Quaglino D
(2007) Biochim Biophys Acta 1774 : 1402-13
30. Elastin receptor (spliced galactosidase) occupancy by elastin peptides counteracts proinflammatory cytokine expression in lipopolysaccharide-stimulated human monocytes through NF-kappaB down-regulation.
Baranek T, Debret R, Antonicelli F, Lamkhioued B, Belaaouaj A, Hornebeck W, Bernard P, Guenounou M, Le Naour R
(2007) J Immunol 179 : 6184-92
29. In vitro comparison of human fibroblasts from intact and ruptured ACL for use in tissue engineering - Discussion with reviewers
Brune T, Borel A, Gilbert TW, Franceschi JP, Badylak SF, Sommer P, Hunt J, Plenk H, Johnstone B
(2007) EUROPEAN CELLS & MATERIALS 14 : 90-91
2006 [Top] 3
28. Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells.
Debret R, Le Naour RR, Sallenave JM, Deshorgue A, Hornebeck WG, Guenounou M, Bernard P, Antonicelli FD
(2006) J Invest Dermatol 126 : 1860-8
27. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
Bouez C, Reynaud C, Noblesse E, Thepot A, Gleyzal C, Kanitakis J, Perrier E, Damour O, Sommer P
(2006) Clin Cancer Res 12 : 1463-9
26. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
Ferrieu-Weisbuch C, Michel S, Collomb-Clerc E, Pothion C, Deleage G, Jolivet-Reynaud C
(2006) J Mol Recognit 19 : 10-20
2005 [Top] 5
25. Inhibition of lysyl oxidase activity can delay phenotypic modulation of chondrocytes in two-dimensional culture.
Farjanel J, Seve S, Borel A, Sommer P, Hulmes DJ
(2005) Osteoarthritis Cartilage 13 : 120-8
24. Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies.
Michel S, Collomb-Clerc E, Geourjon C, Charrier JP, Passagot J, Courty Y, Deleage G, Jolivet-Reynaud C
(2005) J Mol Recognit 18 : 225-35
23. Lysyl oxidase deficiency: a new cause of human arterial dissection.
Sibon I, Sommer P, Lamaziere JM, Bonnet J
(2005) Heart 91 : e33-e33
22. Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome.
Favre-Bonvin A, Reynaud C, Kretz-Remy C, Jalinot P
(2005) J Virol 79 : 4229-37
21. The Pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers.
Thomassin L, Werneck CC, Broekelmann TJ, Gleyzal C, Hornstra IK, Mecham RP, Sommer P
(2005) J Biol Chem 280 : 42848-55
2004 [Top] 3
20. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
Jolivet-Reynaud C, Adida A, Michel S, Deleage G, Paranhos-Baccala G, Gonin V, Battail-Poirot N, Lacoux X, Rolland D
(2004) J Med Virol 72 : 385-95
19. The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells.
Palamakumbura AH, Jeay S, Guo Y, Pischon N, Sommer P, Sonenshein GE, Trackman PC
(2004) J Biol Chem 279 : 40593-600
18. Lysyl oxidase-like and lysyl oxidase are present in the dermis and epidermis of a skin equivalent and in human skin and are associated to elastic fibers.
Noblesse E, Cenizo V, Bouez C, Borel A, Gleyzal C, Peyrol S, Jacob MP, Sommer P, Damour O
(2004) J Invest Dermatol 122 : 621-30
2003 [Top] 3
17. Arrest of mammalian fibroblasts in G1 in response to actin inhibition is dependent on retinoblastoma pocket proteins but not on p53.
Lohez OD, Reynaud C, Borel F, Andreassen PR, Margolis RL
(2003) J Cell Biol 161 : 67-77
16. Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts.
Palamakumbura AH, Sommer P, Trackman PC
(2003) J Biol Chem 278 : 30781-7
15. The mammalian passenger protein TD-60 is an RCC1 family member with an essential role in prometaphase to metaphase progression.
Mollinari C, Reynaud C, Martineau-Thuillier S, Monier S, Kieffer S, Garin J, Andreassen PR, Boulet A, Goud B, Kleman JP, Margolis RL
(2003) Dev Cell 5 : 295-307
2002 [Top] 2
14. Expression analysis of recombinant lysyl oxidase (LOX) in myofibroblastlike cells.
Seve S, Decitre M, Gleyzal C, Farjanel J, Sergeant A, Ricard-Blum S, Sommer P
(2002) Connect Tissue Res 43 : 613-9
13. A molecular role for lysyl oxidase in breast cancer invasion.
Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ
(2002) Cancer Res 62 : 4478-83
2001 [Top] 3
12. Lysyl oxidase-like protein from bovine aorta. Isolation and maturation to an active form by bone morphogenetic protein-1.
Borel A, Eichenberger D, Farjanel J, Kessler E, Gleyzal C, Hulmes DJ, Sommer P, Font B
(2001) J Biol Chem 276 : 48944-9
11. Constrictive bronchiolitis obliterans. Characterisation of fibrogenesis and lysyl oxidase expression patterns.
Streichenberger N, Peyrol S, Philit F, Loire R, Sommer P, Cordier JF
(2001) Virchows Arch 439 : 78-84
10. Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene.
Giampuzzi M, Botti G, Cilli M, Gusmano R, Borel A, Sommer P, Di Donato A
(2001) J Biol Chem 276 : 29226-32
2000 [Top] 3
9. A novel SMAD4 gene mutation in seminoma germ cell tumors.
Bouras M, Tabone E, Bertholon J, Sommer P, Bouvier R, Droz JP, Benahmed M
(2000) Cancer Res 60 : 922-8
8. The mouse lysyl oxidase-like 2 gene (mLOXL2) maps to chromosome 14 and is highly expressed in skin, lung and thymus.
Jourdan-Le Saux C, Le Saux O, Gleyzal C, Sommer P, Csiszar K
(2000) Matrix Biol 19 : 179-83
7. Selective expression of lysyl oxidase (LOX) in the stromal reactions of broncho-pulmonary carcinomas.
Peyrol S, Galateau-Salle F, Raccurt M, Gleyzal C, Sommer P
(2000) Histol Histopathol 15 : 1127-35
1999 [Top] 2
6. Comparative functional study of the lysyl oxidase promoter in fibroblasts, Ras-transformed fibroblasts, myofibroblasts and smooth muscle cells.
Reynaud C, Gleyzal C, Jourdan-Le Saux C, Sommer P
(1999) Cell Mol Biol (Noisy-le-grand) 45 : 1237-47
5. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma.
Trivedy C, Warnakulasuriya KA, Hazarey VK, Tavassoli M, Sommer P, Johnson NW
(1999) J Oral Pathol Med 28 : 246-51
1998 [Top] 1
4. Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas.
Decitre M, Gleyzal C, Raccurt M, Peyrol S, Aubert-Foucher E, Csiszar K, Sommer P
(1998) Lab Invest 78 : 143-51
1997 [Top] 3
3. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.
Peyrol S, Raccurt M, Gerard F, Gleyzal C, Grimaud JA, Sommer P
(1997) Am J Pathol 150 : 497-507
2. Functional analysis of the lysyl oxidase promoter in myofibroblast-like clones of 3T6 fibroblast.
Jourdan-Le Saux C, Gleyzal C, Raccurt M, Sommer P
(1997) J Cell Biochem 64 : 328-41
1. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
Desmouliere A, Darby I, Costa AM, Raccurt M, Tuchweber B, Sommer P, Gabbiani G
(1997) Lab Invest 76 : 765-78